Cochrane review finds PSA screening likely reduces prostate cancer deaths
A Cochrane review of six trials found PSA screening likely reduces prostate cancer deaths by about two per 1,000 men screened.
Read More
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Prostate Cancer
Metformin Mimics Exercise Benefits in Prostate Cancer Patients by Boosting Key Exercise Molecule Production
Metformin raises exercise-related molecule Lac-Phe in prostate cancer patients, mimicking exercise benefits across all disease stages.
Read More